Illustrative image – not actual.Sequent Scientific, an active pharmaceutical ingredient company having presence in Human and Veterinary segments and Specialty chemicals, plans to invest Rs 150 crore in three new therapeutic segments. The investments in these new businesses will be made over the next two years.
The company is expected to set up three new facilities at a greenfield site in Bangalore, for which it has signed a MoU with the Karnataka Government at the Global Investors Meet on 3 June 2010.
Also See:
